- Featured Product
- KD/KO Validated
CYP2W1 Monoklonaler Antikörper
CYP2W1 Monoklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2B10H2
Kat-Nr. : 67419-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67419-1-PBS bindet in WB, IHC, IF/ICC, FC (Intra), Indirect ELISA CYP2W1 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | CYP2W1 fusion protein Ag29982 |
| Vollständiger Name | cytochrome P450, family 2, subfamily W, polypeptide 1 |
| Berechnetes Molekulargewicht | 54 kDa |
| Beobachtetes Molekulargewicht | 45-54 kDa |
| GenBank-Zugangsnummer | BC025761 |
| Gene symbol | CYP2W1 |
| Gene ID (NCBI) | 54905 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cytochrome P450s have been proposed to be of importance both in carcinogenesis, by activating precarcinogens, and as determinants of cancer chemotherapy, where they participate in activation or inactivation of anti-cancer drugs. CYP2W1 is exclusively expressed in transformed tissue in the adult human, mainly in colon tumors. It is a potential drug target in cancer therapy. CYP2W1 has a molecular weight of 52-54 kDa, and 30/45 kDa of potential isoforms.









